Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis by Seko Y, Nishikawa T, Umemura A, Yamaguchi K, Moriguchi M, Yasui K, Kimura M, Iijima H, Hashimoto T, Sumida Y, Okanoue T, Itoh Y

Get full text

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis by Mózes, FE, Lee, JA, Selvaraj, EA, Jayaswal, ANA, Trauner, M, Boursier, J, Fournier, C, Staufer, K, Stauber, RE, Bugianesi, E, Younes, R, Gaia, S, Lupșor-Platon, M, Petta, S, Shima, T, Okanoue, T, Mahadeva, S, Chan, W-K, Eddowes, PJ, Newsome, PN, Wong, VW-S, de Ledinghen, V, Fan, J, Shen, F, Cobbold, JF, Sumida, Y, Okajima, A, Schattenberg, JM, Labenz, C, Kim, W, Lee, MS, Wiegand, J, Karlas, T, Yılmaz, Y, Aithal, GP, Palaniyappan, N, Cassinotto, C, Aggarwal, S, Garg, H, Ooi, GJ, Nakajima, A, Yoneda, M, Ziol, M, Barget, N, Geier, A, Tuthill, T, Brosnan, MJ, Anstee, QM, Neubauer, S, Harrison, SA